Bridges Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Bridges Investment Counsel's ABBV Position: Q4 2017 in Review
Bridges Investment Counsel increased its AbbVie (ABBV) stake by 0.4% in Q4 2017, buying an estimated $16.5K and bringing the position to 44,339 shares worth $4.29M. The position accounts for 2.37% of the portfolio, ranked #8.
Bridges Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. The position peaked at $5.45M in Q2 2017. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.
- Bridges Investment Counsel held 44,339 shares of AbbVie worth $4.29M as of Q4 2017.
- Bridges Investment Counsel bought 175 AbbVie shares in Q4 2017, an estimated $16.5K.
- AbbVie made up 2.37% of Bridges Investment Counsel's portfolio in Q4 2017, its #8 holding.
- Bridges Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
- Bridges Investment Counsel's AbbVie position peaked at $5.45M in Q2 2017.
- 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.
Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.